Skip to main content
BHVN logo

Biohaven Ltd.

BHVNNYSEHealthcareBiotechnology

$14.45Today:- (-)1Y −9.88%

As of Oct 26, 2026 close

Market cap
$2.18B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$7.48$18.57
Volume (live)
-
Avg. volume (3M)
3.38M

Biohaven Ltd. (BHVN) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Biohaven Ltd. stock.

Analyst Consensus Rating

Investment consensus from 13 professional research analysts

Consensus Rating

Buy
Based on 13 unique analysts
(24 total ratings in last 90 days)
High Confidence8.0:1 Buy/Sell

Average Price Target

$23.11
+59.93% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BHVN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$21.00
Brian Skorney
Baird
BuyMaintains
$42.00 → $48.00
Leonid Timashev
RBC Capital
HoldMaintains
$19.00 → $22.00
Edmund Ingham
Forbes
HoldInitiates Coverage
-
Leonid Timashev
RBC Capital
HoldMaintains
$19.00
Dina Ramadane
BofA Securities
SellMaintains
$11.00
Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$21.00
Sumant Kulkarni
Canaccord Genuity
BuyMaintains
$21.00
Samantha Semenkow
Citi
BuyMaintains
$17.00
Samantha Semenkow
Citi
BuyMaintains
$17.00
Tessa Romero
JP Morgan
BuyMaintains
-
Tessa Romero
JP Morgan
BuyMaintains
-
Douglas Tsao
HC Wainwright
HoldMaintains
$10.00
Myles Minter
William Blair
HoldReiterates
-
Christopher Raymond
Raymond James
BuyMaintains
-
Myles Minter
William Blair
HoldInitiates Coverage
-
Leonid Timashev
RBC Capital
HoldDowngrades
$23.00 → $19.00
Edmund Ingham
Forbes
BuyInitiates Coverage
-
Dina Ramadane
BofA Securities
SellReiterates
$11.00
Dina Ramadane
BofA Securities
SellReiterates
$11.00
Allison Bratzel
Piper Sandler
BuyMaintains
$30.00
Terence Flynn
Morgan Stanley
BuyMaintains
$19.00
Tyler Van Buren
TD Cowen
BuyMaintains
$30.00
Leonid Timashev
RBC Capital
BuyMaintains
$22.00 → $23.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 23, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for BHVN?

The analyst consensus rating for BHVN is Buy, based on the latest ratings from 13 analysts over the last 90 days.

What is the average price target for BHVN?

The average 12-month price target for BHVN is $23.11, representing an upside of 59.9% from the Oct 26, 2026 close of $14.45.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.